Haijun Huang

158 Shangtang Road
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Stepwise KPC mutational accumulation confers high-level ceftazidime-avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae.

Stepwise KPC mutational accumulation confers high-level ceftazidime-avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: March 04, 2026

A machine learning predictive model for staging chronic hepatitis B inflammation based on non-invasive metrics.

A machine learning predictive model for staging chronic hepatitis B inflammation based on non-invasive metrics.

Journal: Scientific reports

Published: January 25, 2026

Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 08, 2025

Association between early antibiotic treatment after admission and mortality of acute-on-chronic liver failure patients with bacterial infection: A multicenter retrospective study.

Association between early antibiotic treatment after admission and mortality of acute-on-chronic liver failure patients with bacterial infection: A multicenter retrospective study.

Journal: Virulence

Published: May 30, 2025

DNA, RNA, and histone methylation regulation enzymes and their crosstalk in colorectal carcinogenesis and progression: a review of molecular mechanisms, clinical implications, and future perspectives.

DNA, RNA, and histone methylation regulation enzymes and their crosstalk in colorectal carcinogenesis and progression: a review of molecular mechanisms, clinical implications, and future perspectives.

Journal: Cellular & molecular biology letters

Published: May 25, 2025

MELD 3.0 Improves Risk Stratification and Mortality Prediction in Hepatorenal Syndrome-Acute Kidney Injury: A Multicentre Study.

MELD 3.0 Improves Risk Stratification and Mortality Prediction in Hepatorenal Syndrome-Acute Kidney Injury: A Multicentre Study.

Journal: Alimentary pharmacology & therapeutics

Published: March 03, 2025

Editorial: Assessing the Prognosis of Patients With HBV and ACLF-Comorbidities Matter. Authors' Reply.

Editorial: Assessing the Prognosis of Patients With HBV and ACLF-Comorbidities Matter. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: October 30, 2024

Noninvasive diagnosis model for predicting significant liver inflammation in patients with chronic hepatitis B in the immune-tolerant phase.

Noninvasive diagnosis model for predicting significant liver inflammation in patients with chronic hepatitis B in the immune-tolerant phase.

Journal: Scientific reports

Published: July 03, 2024

Comparisons of efficacy and safety of 400 or 800 ml bacterial count fecal microbiota transplantation in the treatment of recurrent hepatic encephalopathy: a multicenter prospective randomized controlled trial in China.

Comparisons of efficacy and safety of 400 or 800 ml bacterial count fecal microbiota transplantation in the treatment of recurrent hepatic encephalopathy: a multicenter prospective randomized controlled trial in China.

Journal: Trials

Published: June 28, 2024

aCCI-HBV-ACLF: A Novel Predictive Model for Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.

aCCI-HBV-ACLF: A Novel Predictive Model for Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.

Journal: Alimentary pharmacology & therapeutics

Published: June 11, 2024

Idiopathic mesenteric phlebosclerosis occurring in a patient with liver cirrhosis: A case report.

Idiopathic mesenteric phlebosclerosis occurring in a patient with liver cirrhosis: A case report.

Journal: Medicine

Published: March 15, 2024

Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver.

Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver.

Journal: Hepatology (Baltimore, Md.)

Published: March 04, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026